These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 3281822)

  • 1. Aspirin in cardiovascular disease.
    Reilly IA; FitzGerald GA
    Drugs; 1988 Feb; 35(2):154-76. PubMed ID: 3281822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
    Aronow WS
    Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin as an antithrombotic drug: from the aggregometer to clinical trials.
    de Gaetano G
    Verh K Acad Geneeskd Belg; 1990; 52(6):459-71; discussion 471-3. PubMed ID: 2150736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy in the prevention of ischaemic stroke.
    Verry M; Panak E; Cazenave JP
    Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):213-28. PubMed ID: 7971242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.
    Berger JS; Krantz MJ; Kittelson JM; Hiatt WR
    JAMA; 2009 May; 301(18):1909-19. PubMed ID: 19436018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current issues in thrombosis prevention with antiplatelet drugs.
    de Gaetano G; Cerletti C; Dejana E; Vermylen J
    Drugs; 1986 Jun; 31(6):517-49. PubMed ID: 3525085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Low-dose aspirin in the long-term treatment of the patient with ischemic heart disease].
    Magnani B; Semprini F
    Cardiologia; 1994 Dec; 39(12 Suppl 1):15-21. PubMed ID: 7634259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
    Hennekens CH; Sacks FM; Tonkin A; Jukema JW; Byington RP; Pitt B; Berry DA; Berry SM; Ford NF; Walker AJ; Natarajan K; Sheng-Lin C; Fiedorek FT; Belder R
    Arch Intern Med; 2004 Jan; 164(1):40-4. PubMed ID: 14718320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular biology of thrombosis: platelet-vessel wall interactions and aspirin effects.
    Catella-Lawson F
    Neurology; 2001; 57(5 Suppl 2):S5-7. PubMed ID: 11552047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
    Mehta SR; Yusuf S;
    Eur Heart J; 2000 Dec; 21(24):2033-41. PubMed ID: 11102254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
    BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of therapeutic interventions in myocardial infarction. Emphasis on secondary prevention.
    Hinstridge V; Speight TM
    Drugs; 1991; 42 Suppl 2():8-20. PubMed ID: 1718703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet agents in coronary artery disease.
    Schrader BJ; Berk SI
    Clin Pharm; 1990 Feb; 9(2):118-24. PubMed ID: 2407421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention.
    Prescrire Int; 2000 Jun; 9(47):83-5. PubMed ID: 11010749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet inhibitor agents in cardiovascular disease: an update.
    Stein B; Fuster V; Israel DH; Cohen M; Badimon L; Badimon JJ; Chesebro JH
    J Am Coll Cardiol; 1989 Oct; 14(4):813-36. PubMed ID: 2677086
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.